Below we present the list of Top 5 Earnings Growth Stocks with Dividends for 2021.
Keep Reading →
November 29 - Dividend Stocks, Hedge Fund Analysis, Hedge Funds, News
Ray Dalio is the billionaire Founder, Co-Chairman and Co-Chief Investment Officer of Bridgewater Associates, the largest hedge fund in the world with over $140 billion in assets...
Keep Reading →
November 15 - Hedge Fund Analysis, Hedge Funds, News
Kyle Bass, the often-bearish hedge-fund manager who won big during the global financial crisis, has trained his sights anew on the Hong Kong dollar. Mr.
Keep Reading →
April 25 - Hedge Funds, Insider Trading
Financier Ray Dalio is on a mission to let everyone know that wealth inequality has become so extreme it is driving a dangerous wedge in society.
Keep Reading →
April 8 - Hedge Funds, Insider Trading
What happened: Shares of industrial supplier WW Grainger Inc (NYSE:GWW) jumped as much as 17.4% in trading Wednesday after the company reported fourth-quarter results that topped...
Keep Reading →
January 24 - Market Movers, News
Alere Inc (NYSE:ALR) has surged 16% in the pre-market after the Abbott Laboratories (NYSE:ABT) finally bit the bullet and agreed to an amended merger to buy Alere for $51 per...
Keep Reading →
April 17 - Market Movers, News
GDS Investments, a premier investment management firm headed by Glenn D.
Keep Reading →
March 15 - Hedge Fund Analysis, News
Locust Wood Capital Advisers is a New York-based hedge fund that was founded in 2002 by Stephen J. Errico with a capital of $29 million.
Keep Reading →
February 6 - Hedge Funds, News
The Abbott RealTime ZIKA molecular test from Abbott Laboratories (NYSE:ABT) has gained the approval of the U.S. Food and Drug Administration (FDA).
Keep Reading →
February 3 - News, Stock Analysis
The Tendril MRI pacing lead and the Assurity MRI pacemaker have been approved by the U.S. Food and Drug Administration.
Keep Reading →
February 2 - News, Stock Analysis
Abbott Laboratories (NYSE:ABT)'s dorsal root ganglion (DRG) stimulation therapy has advantages over traditional spinal cord stimulation (SCS) in the treatment of patients suffering...
Keep Reading →
January 18 - News, Stock Analysis
Alinity, a family of next-generation clinical chemistry and immunoassay diagnostics from Abbott Laboratories (NYSE:ABT) is now being offered in Europe and other countries that...
Keep Reading →
January 11 - News, Stock Analysis
Corporate insiders such as Board members and executives usually buy shares on the open market for one simple reason – they believe Mr.
Keep Reading →
December 27 - Insider Trading, News
Stanley Druckenmiller was one of the fund managers for the Quantum Fund founded by George Soros.
Keep Reading →
December 23 - Dividend Stocks, Hedge Funds, News
Each week I review the list of dividend increases as part of my monitoring process.
Keep Reading →
December 19 - Dividend Stocks, News, Stock Analysis
Abbott Laboratories (NYSE:ABT) has sued Alere Inc (NYSE:ALR), a diagnostics company it agreed to acquire earlier this year, for breach of contract.
Keep Reading →
November 4 - News, Stock Analysis
Mairs & Power is a Minnesota-based hedge fund with $4.32 billion worth of assets invested in 52 holdings in its U.S. public equity portfolio.
Keep Reading →
November 4 - Hedge Fund Analysis, Hedge Fund Investor Letters, Hedge Funds, News
Billionaire George Soros has been in the news a lot during the current Presidential elections, most recently being at the center of controversy over his ties to a company that...
Keep Reading →
October 31 - Hedge Fund Analysis, Hedge Funds, News
Markets are mixed on Wednesday as investors get ready to digest a flurry of earnings, and await Federal Reserve’s summary of commentary of the current economic condition, also...
Keep Reading →
October 19 - Earnings Report, Market Movers, News
Dividend Aristocrats have passed the test of time.
Keep Reading →
October 1 - Dividend Stocks, Hedge Funds, News
According to the latest 13F filing of Sio Capital, a global equity market healthcare hedge fund, the investment advisory has further increased its exposure in the healthcare industry...
Keep Reading →
September 27 - Hedge Fund Analysis, Hedge Funds, News
With another quarter almost in the rear-view mirror, many investors are adjusting their portfolios in reaction to the latest news.
Keep Reading →
September 18 - Market Movers, News
Antitrust regulations, tax rules and political uncertainty marred the Merger & Acquisitions (M&A) activity in the second quarter of 2016.
Keep Reading →
July 22 - Hedge Funds, News, Tech
Most investors are smiling today, as the US stock market continues its rally, with the Dow setting a new intraday high.
Keep Reading →
July 20 - Earnings Report, Market Movers, News
Crude futures are in the red today after yesterday's disappointing API inventory report, but the market is in the green following strong financial results posted by several big...
Keep Reading →
July 20 - Earnings Report, News
Some potential upside/downside catalysts in the upcoming week include today's EIA inventory release and tomorrow's jobless claims report.
Keep Reading →
July 13 - Market Movers, News
The world is aging. The average global population age is increasing.
Source: The Economist
This means there are more middle-aged and elderly people than ever before. This trend is expected to continue far into the future.
Keep Reading →
May 31 - Dividend Stocks, News, Stock Analysis
Founded in 2000 by Ric Dillon, Diamond Hill Capital employs a value investing approach to stock picking and had approximately $18 billion in assets under management at the end...
Keep Reading →
May 14 - Hedge Fund Analysis, Hedge Funds, News
On a day when the major indexes are each down by two-thirds of a percentage point, Delta Air Lines, Inc. (NYSE:DAL), Alere Inc (NYSE:ALR), Caterpillar Inc.
Keep Reading →
April 29 - Market Movers, News
The S&P 500 opened lower on Thursday as investors refocus on the weak global macro-economic picture.
Keep Reading →
April 28 - Market Movers, News, Tech
It's a rather flat day on Wall Street, as all three major indexes are hovering around level ground for the day.
Keep Reading →
April 20 - Market Movers, News
Arthur B. Cohen and Joseph Healey's HealthCor Management has nearly $2.6 billion worth of regulatory assets under its management.
Keep Reading →
December 8 - Hedge Fund Analysis, Hedge Funds, News
Abbott Laboratories has been wildly successful in its long history. The company’s success is not a historical relic; Abbott has positioned itself well to take advantage of...
Keep Reading →
December 3 - Dividend Stocks, News, Stock Analysis
A report from Financial Times mentioning a potential acquisition bid for St. Jude Medical, Inc.
Keep Reading →
August 27 - Hedge Funds, News
Unfortunately, most investors don’t know about the market-beating returns of Dividend Aristocrats during recessions. In 2008, the S&P 500 fell around 37%.
Keep Reading →
August 26 - Dividend Stocks, News, Stock Analysis
Pershing Square, managed by billionaire Bill Ackman, recently filed with the U.S.
Keep Reading →
February 19 - Hedge Funds, News
Animal health care company, Zoetis Inc (NYSE:ZTS) is doing extremely well according to activist investor Bill Ackman of Pershing Square, having agreed to add two members to the...
Keep Reading →
February 13 - News
The story was picked up by the major news sources a few years ago as a "cute" human interest feature.
Keep Reading →
October 2 - Dividend Stocks, Stock Analysis
While Foolish readers know all too well that a good turnaround story can drive excellent shareholders, sometimes discretion is the better part of valor and it makes more sense...
Keep Reading →
September 13 - News
Since 1983, Depakote ER has been a good source of revenue for drug manufacturers. The drug is mainly used in the treatment of bipolar disorder, migraines, and seizures.
Keep Reading →
September 13 - News
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown.
Keep Reading →
September 3 - News
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)'s Belviq, VIVUS, Inc. (NASDAQ:VVUS)'s Qsymia, and Orexigen Therapeutics, Inc. (NASDAQ:OREX)'s Contrave were rejected by the Food and...
Keep Reading →
August 29 - News
The medical-device industry isn't probably the first place you'd think to find great, high-yielding dividend stocks.
Keep Reading →
August 29 - News
To the average investor, there are a multitude of metrics shareholders can use to analyze stocks. Some of the most useful are hedge fund and insider trading movement.
Keep Reading →
August 26 - News
Now, according to many of your fellow readers, hedge funds are perceived as useless, old investment vehicles of a period lost to current times.
Keep Reading →
August 23 - News
The benefits to investing in emerging markets have become well known over the course of the last decade.
Keep Reading →
August 23 - News
When a company is spun off, there's a high level of forced selling.
Keep Reading →
August 21 - News
It is often said that the real cure for HIV and AIDS will come from better, more discrete testing procedures, and not from the drug cocktails made by Gilead Sciences, GlaxoSmithKline...
Keep Reading →
August 20 - News
A strong week for investors ended especially well in China, as Hong Kong's HANG SENG INDEX (INDEXHANGSENG:HSI) index jumped by 3.3% for the week.
Keep Reading →
August 19 - News
These days there doesn't seem to be much in the way of economic news that can stop the ascent of the broad-based S&P 500 .
Keep Reading →
August 7 - News